RealityCheck™
Are there gaps in your primary annual research? Are you aware of a bias in your data, but you are unsure how that bias affects results? You may need a RealityCheck™, and we can provide that for you.
TrackerPlus™
Is your product an injectable in pre-launch or already competing in a heavily dynamic market? Do you need a reliable way to track changes in post-launch patient usage or market share of your drug vs. each competitor?
Clarity Pharma can traverse sections of the globe with you, whether you are sizing a market in the United States, studying adherence to treatment guidelines in Japan, or comparing disease practice patterns in Canada.
Featured Services
- Pre-, post-launch treatment patterns
- Sizing the market
- Measuring clinical utility
Verifying clinical trial parameters- Mapping the competitive landscape
- Identifying post-launch obstacles and opportunities
- Measuring product uptake
- Indications and off-label usage
- Patient share vs. drug share
- Tracking market changes
- Segmentation
- Product positioning and differentiation
Measuring adherence to protocol
- Delphi method consensus building
- Epidemiologic studies
- Econometric modeling
• Asia:
– Japan
– China
– India
– Turkey
© 2014-2023 Clarity Pharma Research® LLC | All Rights Reserved | Privacy Policy
To learn more about our services, contact information@claritypharma.com.
Whether your product is pre-launch, post-launch, or established in the market and facing new competition, our custom-designed primary research answers key business questions and can fill critical gaps in your claims or syndicated data.
• United States
• Canada
South & Central America:
– Mexico
– Brazil
FactPlus™
Are you using the best research tools to understand the market? Are your data reliable and is your sample representative? If not, we can help your company with FactPlus™, a reality-based patient records study.
Global Capabilities
FactOp™
Do all of your research projects together yield ONE cohesive story, or does your ATU study disagree in some ways with your supplier's chart audit? We have a solution that coalesces perceptual and empirical data.